Publications

Authors:

Caminati, Marco; Brussino, Luisa; Carlucci, Matilde; Carlucci, Palma; Carpagnano, Lucia Federica; Caruso, Cristiano; Cosmi, Lorenzo; D'Amore, Simona; Del Giacco, Stefano; Detoraki, Aikaterini; Di Gioacchino, Mario; Matucci, Andrea; Mormile, Ilaria; Granata, Francescopaolo; Guarnieri, Gabriella; Krampera, Mauro; Maule, Matteo; Nettis, Eustachio; Nicola, Stefania; Noviello, Silvia; Pane, Fabrizio; Papayannidis, Cristina; Parronchi, Paola; Pelaia, Girolamo; Ridolo, Erminia; Rossi, Francesca Wanda; Senna, Gianenrico; Triggiani, Massimo; Vacca, Angelo; Vivarelli, Emanuele; Vultaggio, Alessandra; de Paulis, Amato

Title:

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Year:

2024

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Referee:

No

Name of journal:

CELLS

ISSN of journal:

2073-4409

N° Volume:

13

Number or Folder:

14

Page numbers:

1-14

Keyword:

eosinophils; hypereosinophilia; hypereosinophilic syndrome; management; mepolizumab; network; precision medicine

Short description of contents:

Hypereosinophilic syndrome (HES) encompasses a heterogeneous and complex group of different subtypes within the wider group of hypereosinophilic disorders. Despite increasing research interest, several unmet needs in terms of disease identification, pathobiology, phenotyping, and personalized treatment remain to be addressed. Also, the prospective burden of non-malignant HES and, more in general, HE disorders is currently unknown. On a practical note, shortening the diagnostic delay and the time to an appropriate treatment approach probably represents the most urgent issue, even in light of the great impact of HES on the quality of life of affected patients. The present document represents the first action that the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) has finalized within a wider project aiming to establish a collaborative national network on HES (InHES-Italian Network on HES) for patients and physicians. The first step of the project could not but focus on defining a common language as well as sharing with all of the medical community an update on the most recent advances in the field. In fact, the existing literature has been carefully reviewed in order to critically integrate the different views on the topic and derive practical recommendations on disease identification and treatment approaches.

Product ID:

144441

Handle IRIS:

11562/1155689

Last Modified:

May 8, 2025

Bibliographic citation:

Caminati, Marco; Brussino, Luisa; Carlucci, Matilde; Carlucci, Palma; Carpagnano, Lucia Federica; Caruso, Cristiano; Cosmi, Lorenzo; D'Amore, Simona; Del Giacco, Stefano; Detoraki, Aikaterini; Di Gioacchino, Mario; Matucci, Andrea; Mormile, Ilaria; Granata, Francescopaolo; Guarnieri, Gabriella; Krampera, Mauro; Maule, Matteo; Nettis, Eustachio; Nicola, Stefania; Noviello, Silvia; Pane, Fabrizio; Papayannidis, Cristina; Parronchi, Paola; Pelaia, Girolamo; Ridolo, Erminia; Rossi, Francesca Wanda; Senna, Gianenrico; Triggiani, Massimo; Vacca, Angelo; Vivarelli, Emanuele; Vultaggio, Alessandra; de Paulis, Amato, Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) «CELLS» , vol. 13 , n. 14 , 2024 , pp. 1-14

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo